FindTrial
Sign In

Drug prescription pattern and adverse drug reactions in burns patients

A cross sectional study of drug prescribing pattern and adverse drug reactions in burns patients at a tertiary care hospital

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/041113
Enrollment
90
Registered
2022-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T312- Burns involving 20-29% of body surface Health Condition 2: T313- Burns involving 30-39% of body surface Health Condition 3: T314- Burns involving 40-49% of body surface Health Condition 4: T315- Burns involving 50-59% of body surface

Interventions

Intervention1: NIL: NIL

Sponsors

BMCRI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with burns with moderate to severe burns (ABA criteria) with total burnt surface area being 20-60% according to Lund and Browderââ?¬•s chart

Exclusion criteria

Exclusion criteria: Pregnant and lactating mothers. Age of the patient 60 years Total Burnt surface area 60%

Design outcomes

Primary

MeasureTime frame
Demographic data, medical history, concomitant medications, intercurrent illness, physical examination, clinical examination including recording of vital signs, clinical examination and details of any other will be recorded in the case record form (CRF). History of adverse drug reactions in the first 2 hour period is also documented. Timepoint: 24 hour post admission—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactRaghav M V

Bangalore Medical College and research institute

geetha25bmcri@gmail.com8105702966

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026